Boston Scientific accounts are for healthcare professionals only.
We were thrilled to showcase the Intracept™ Procedure and the WaveWriter Alpha™ Spinal Cord Stimulator System in Miami Beach.
View Highlights from ASPN 2025
Advancing outcomes for your patients and practice
Boston Scientific’s Intracept Procedure is the only vertebrogenic pain solution with 5-year RCT data proving safety, efficacy and durability.1
The WaveWriter Alpha SCS system delivers PROFOUND pain relief PROVEN by clinical data, and is DIFFERENT – designed to succeed where others fail, and get it right the first time.2-6
- Fischgrund J, Rhyne A, Macadaeg K, et al. Long-term outcomes following intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 5-year treatment arm results from a prospective randomized double-blind sham-controlled multi-center study. Eur Spine J. 2020;29(8):1925-34. doi.org/10.1007/s00586-020-06448-x
- Metzger C., et al. Two-year Outcomes Using Fast-Acting Sub-perception Therapy for Spinal Cord Stimulation: Results of a Real-World Multicenter Study in the United States. Expert Rev Med Devices. Published online January 2025.
- Bayerl S, Paz-Solis J, Matis G, et al. Two-year outcomes using fast-acting, sub-perception therapy for spinal cord stimulation: a European, real-world, multicenter experience. JCM. 2024;13(22):6999
- Anitescu M., et al. Utilizing SCS Designed to Engage Surround Inhibition Using Fast-Acting Sub-Perception Therapy (FAST): Prospective, Multicenter, Long-Term Outcomes [Abstract] NAANS 2025 Annual Meeting, Jan 30-Feb 1, 2025.
- Haider N, Ligham D, Quave B, et al. Spinal cord stimulation (SCS) trial outcomes after conversion to a multiple waveform scs system. Neuromodulation. 2018;21(5):504-507.
- Rigoard P, Billot M, Bougeard R, et al. Improved outcomes and therapy longevity after salvage using a novel spinal cord stimulation system for chronic pain: multicenter, observational, European case series. J Clin Med. 2024;13(4):1079.
The WaveWriter Alpha™ SCS System provides safe access to full-body MRI scans when used with specific components and the patient is exposed to the MRI environment under the defined conditions in the ImageReady™ MRI Full Body Guidelines for WaveWriter Alpha and WaveWriter Alpha Prime Spinal Cord Stimulator System.
Results from clinical studies are not predictive of results in other studies. Results in other studies may vary.
Warning: Stimulation modes. Only paresthesia-based stimulation mode has been evaluated for effectiveness in the diabetic peripheral neuropathy (DPN) population.